Čtvrtina úmrtí na ebolu v Kongu připadá na děti. USA uvolní lék

An Ebola epidemic is spreading in the Democratic Republic of Congo, particularly in the northeastern Ituri province. Approximately 15 percent of confirmed cases and more than 25 percent of all deaths affect children and adolescents, due to malnutrition and poor health conditions. According to UNICEF, more than 130 children have lost their parents as a result of Ebola. The United States has released the experimental drug MBP134 by Mapp Biopharmaceutical for clinical testing in DRC, representing a change in their previous approach. The WHO plans to begin clinical trials of two antivirals by Gilead Sciences in the coming weeks. According to WHO, 115 million USD is needed to combat Ebola in Congo.